Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • No Plea From Pharma...

    No Plea From Pharma Industry to Resolve Issues With USFDA: Govt

    Written by savita thakur thakur Published On 2016-05-05T13:06:59+05:30  |  Updated On 5 May 2016 1:06 PM IST
    No Plea From Pharma Industry to Resolve Issues With USFDA: Govt

    New Delhi : Domestic pharmaceutical industry has not approached the government for early intervention to resolve regulatory issues faced by them in the US, Parliament was informed.


    "There is no representation from the industry to the government for early intervention and dialogue with the US health regulator," Minister of State for Commerce and Industry Nirmala Sitharaman said in a written reply to the Rajya Sabha.


    Despite the regulatory action by the US Food and Drug Administration (USFDA), Indian pharmaceutical exports to the US have increased from USD 3.4 billion in 2013-14 to USD 3.8 billion in 2014-15, she added.


    On steps being taken by the government to grow domestic pharma industry, Sitharaman said, "India and the US are collaborating in information sharing about good manufacturing practices, inspections, capacity building of inspectors and industry."


    In recent times various Indian drug firms Sun Pharmaceuticals, Wockhardt, Dr Reddy's Laboratories, Cadila Healthcare have come under the USFDA scanner for various reasons including manufacturing norms violations at their respective facilities.


    The USFDA has refused entry of 12,012 Indian products, including drugs, into the American market between January 2011 and March 2016 for various reasons.


    The reasons given for the refusal include misbranding, adulteration, packaging, labelling, pesticides, unapproved products and the like.

    Cadila HealthcareDr Reddy'sIndiaNirmala SitharamanPharma Industrypharma news indiaSun PharmaUS Food and Drug AdministrationUSFDAWockhardt
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok